Comparison of Clinical Characteristics of Pneumococcal and non-Pneumococcal Streptococcal Pneumonia

被引:0
|
作者
Jo, Yu Mi [1 ]
Song, Young [1 ]
Choi, Won Suk [1 ]
Heo, Jung Yeon [1 ]
Noh, Ji Youn [1 ]
Kim, Woo Joo [1 ]
Cheong, Hee Jin [1 ]
机构
[1] Korea Univ, Coll Med, Dept Internal Med, Seoul, South Korea
关键词
Community-acquired pneumonia; Pneumococcal pneumonia; Streptococcus;
D O I
10.3947/ic.2010.42.4.223
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Although Pneumococcal (SPN) pneumonia is the most common cause of community-acquired pneumonia, non-pneumococcal streptococcal (NSPN) pneumonia is also frequently reported. However, there are insufficient data on characteristics of NSPN pneumonia which makes it difficult to decide treatment plans or to assess the prognosis. Materials and Methods: Between March 2002 and February 2009, medical records including clinical and epidemiological data on patients aged >= 18 years with community-acquired streptococcal pneumonia were reviewed retrospectively. Clinical characteristics were compared between community-acquired NSPN pneumonia and SPN pneumonia. Results: During the 7 year study periods, 248 patients were hospitalized with community-acquired streptococcal pneumonia and 30 of them had NSPN pneumonia. There were 12 cases of Streptococcus constellatus, 7 cases of S. anginosus, 4 cases of S. mitis, 3 cases of S. pyogenes, 2 cases of S. oralis, 1 case of S. alactolyticus and 1 case of S. agalactiae. There was no difference in percentage of patients with a chronic underlying disease between SPN and NSPN pneumonia groups. The most common was chronic obstructive pulmonary disease (SPN 29.8%, NSPN 16.7%) followed by diabetes mellitus (SPN 22.0%, NSPN 13.3%). Bacteremia (SPN 7.3%, NSPN 20.0%, P=0.04) and empyema (SPN 1.4%, NSPN 53.3%, P<0.001) were more common in NSPN pneumonia. However, there was no significant difference in the CURB-65 pneumonia severity score and 30-day mortality between the two groups. According to multivariate analysis results, the significant risk factor for NSPN pneumonia was the history of frequent alcohol drinking (Adjusted OR 3.81, 95% CI 1.36 to 10.67). Conclusion: Pneumonia caused by NPSN is more commonly accompanied by bacteremia and empyema compared to SPN pneumonia, but there was no difference in the 30-day mortality between the two groups. NSPN pneumonia should be considered if a patient with a history of chronic alcoholism presents with pneumonia and pleural effusion, especially when Gram positive diplococci is seen in the sputum Gram stain.
引用
收藏
页码:223 / 229
页数:7
相关论文
共 50 条
  • [1] Pneumococcal pneumonia
    Sevieri, Gianfranco
    Spacone, Antonella
    Pela, Riccardo
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2011, 6 (06): : 377 - 386
  • [2] Clinical characteristics and outcome of complicated pneumococcal pneumonia in a pediatric population
    Wexler, Isaiah D.
    Knoll, Sharon
    Picard, Eli
    Villa, Yael
    Shoseyov, David
    Engelhard, Dan
    Kerem, Eitan
    PEDIATRIC PULMONOLOGY, 2006, 41 (08) : 726 - 734
  • [3] Pneumococcal conjugate vaccine herd effects on non-invasive pneumococcal pneumonia in elderly
    van Werkhoven, Cornelis H.
    Hollingsworth, Rosalind C.
    Huijts, Susanne M.
    Bolkenbaas, Marieke
    Webber, Chris
    Patterson, Scott
    Sanders, Elisabeth A. M.
    Bonten, Marc J. M.
    VACCINE, 2016, 34 (28) : 3275 - 3282
  • [4] Pneumococcal pneumonia in the era of heptavalent pneumococcal conjugate vaccine
    Payeras, Antoni
    Villoslada, Aroa
    Garau, Margarita
    Borras, Maria
    Pareja, Antonio
    Beingolea, David
    Garcia-Gasalla, Mercedes
    del Carmen Gallegos, M.
    Jose Alonso-Villaverde, Carlos
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2011, 29 (04): : 250 - 256
  • [5] CLINICAL AND MICROBIOLOGICAL CHARACTERISTICS OF PAEDIATRIC PATIENTS HOSPITALIZED FOR PNEUMOCOCCAL PNEUMONIA BEFORE AND AFTER THE INTRODUCTION OF PNEUMOCOCCAL CONJUGATE VACCINES
    Gomez, Carolina A.
    Gonzales, Brayan E.
    Hernandez, Roger A.
    Campos, Francisco
    Chaparro, Eduardo
    Del aguila, Olguita
    Castillo, Maria E.
    Saenz, Andres
    Reyes, Isabel
    Ochoa, Theresa J.
    REVISTA PERUANA DE MEDICINA EXPERIMENTAL Y SALUD PUBLICA, 2025, 42 (01):
  • [6] Pneumococcal pneumonia
    Maurice A. Mufson
    Current Infectious Disease Reports, 1999, 1 (1) : 57 - 64
  • [7] Usefulness of Sofia Pneumococcal FIAA® test in comparison with BinaxNOWA® Pneumococcal test in urine samples for the diagnosis of pneumococcal pneumonia
    Burgos, Joaquin
    Garcia-Perez, Jorge N.
    Gonzalez di Lauro, Sabina
    Falco, Vicenc
    Pumarola, Tomas
    Almirante, Benito
    Martin Gomez, M. Teresa
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2018, 37 (07) : 1289 - 1295
  • [8] Impact of the emergence of non-vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia
    Burgos, J.
    Falco, V.
    Borrego, A.
    Sorde, R.
    Larrosa, M. N.
    Martinez, X.
    Planes, A. M.
    Sanchez, A.
    Palomar, M.
    Rello, J.
    Pahissa, A.
    CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (04) : 385 - 391
  • [9] Usefulness of Sofia Pneumococcal FIA® test in comparison with BinaxNOW® Pneumococcal test in urine samples for the diagnosis of pneumococcal pneumonia
    Joaquin Burgos
    Jorge N. Garcia-Pérez
    Sabina González di Lauro
    Vicenç Falcó
    Tomás Pumarola
    Benito Almirante
    M. Teresa Martín Gomez
    European Journal of Clinical Microbiology & Infectious Diseases, 2018, 37 : 1289 - 1295
  • [10] Emerging drugs for pneumococcal pneumonia
    Falco, Vicenc
    Sanchez, Ana
    Pahissa, Albert
    Rello, Jordi
    EXPERT OPINION ON EMERGING DRUGS, 2011, 16 (03) : 459 - 477